SCHEMBL14033666

SCHEMBL14033666

Clc1ccc(C(Cl)c2cccc3ncccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 2/20 0.48
EIF4H Q15056 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
ANO1 Q5XXA6 1/20 0.39
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FADS1 O60427 1/20 0.38
NR4A2 P43354 2/20 0.38
POLB P06746 1/20 0.37
CNR1 P21554 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14034247 0.89 CNR1 (0.43) PABPC1EIF4HMEN1KMT2AL3MBTL1
SCHEMBL14033360 0.84 L3MBTL1 (0.48) PABPC1EIF4HMEN1KMT2AL3MBTL1
SCHEMBL14033971 0.76 L3MBTL1 (0.47) MEN1KMT2AL3MBTL1KDM4EMAPT
SCHEMBL3749378 0.75 MAPT (0.48) PABPC1EIF4HMEN1KMT2AL3MBTL1
SCHEMBL30575775 0.75 CYP2C19 (0.47) L3MBTL1ALDH1A1KDM4EMAPTLMNA
SCHEMBL14033462 0.75 CYP2C19 (0.47) L3MBTL1ALDH1A1KDM4EMAPTLMNA
SCHEMBL27335432 0.71 MAPT (0.44) MEN1KMT2AL3MBTL1ALDH1A1KDM4E
SCHEMBL14034054 0.71 LMNA (0.48) L3MBTL1ALDH1A1KDM4EMAPTLMNA
SCHEMBL30994907 0.71 MAPT (0.52) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL22049618 0.71 MAPT (0.52) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed